NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 2 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -53.8% | 53,672 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -18.8% | 53,672 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | -20.0% | 53,672 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $20,000 | -41.2% | 53,672 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -2.9% | 53,672 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $35,000 | -28.6% | 53,672 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $49,000 | +32.4% | 53,672 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $37,000 | -7.5% | 53,672 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $40,000 | – | 53,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 46,903 | $34,000 | 0.01% |
| TOWNSQUARE CAPITAL LLC | 53,672 | $40,000 | 0.00% |
| NVWM, LLC | 2,997 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 152,309 | $111,000 | 0.00% |
| UBS Group AG | 2,000 | $1,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $18,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 2,000 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,260 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,000 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,514 | $5,000 | 0.00% |